-
Experts to review challenging cases from the cardiometabolic clinic
Diabetes is not just an endocrine disease. It is a cardiometabolic disease that benefits from multidisciplinary care. Goutham Rao, MD, and other panelists will discuss an interdisciplinary approach to diabetes care.
-
Diabetes Care Symposium to present new insights from implementation science and strategies for best-practice diabetes care
This year’s symposium from the premier clinical research journal of the ADA will focus on strategies to facilitate the delivery of guideline-recommended care for type 2 diabetes prevention and management.
-
Head of FDA to open 84th Scientific Sessions
The leader of the U.S. Food and Drug Administration (FDA), Robert M. Califf, MD, will address the diabetes professionals gathered in Orlando as part of the Welcome to the 84th ADA Scientific Sessions—Keynote Address and Panel Discussion.
-
Pathway to Stop Diabetes nominations are open; symposium to feature program awardees
The Pathway to Stop Diabetes® aims to identify the new generation of scientists at the peak of their creativity and provide them with the autonomy and resources to achieve breakthrough discoveries.
-
Experts to debate how race- and ethnicity-based cut points in diabetes screening and diagnosis affect disparities
Quyen Ngo-Metzger, MD, MPH, will present the case that the use of race- and ethnicity-based cut points can potentially reduce health disparities in the diagnosis of diabetes. Jessica Cerdeña, MD, PhD, will argue that the harm of using such cut points may outweigh the benefit when it comes to addressing health disparities.
-
ADA-CDC Joint Symposium will explore trends in diabetes-related complications and prevention of secondary diabetes
Ryan Saelee, PhD, MPH, and other experts will review recent trends and disparities in, as well as approaches for preventing, diabetes-related complications. Topics include self-management and care, policy, systems, and environmental strategies for secondary diabetes prevention.
-
Engage with colleagues and industry leaders at special events on Friday
Scientific Sessions attendees have numerous opportunities to engage with the diabetes health care and research community, including industry leaders working to develop new therapies and tools for the more than 537 million people living with diabetes worldwide, during the live meeting in Orlando.
-
Symposium on drugs used for diabetic retinopathy to include LENS results
David Preiss, MBChB, MRCP, FRCPath, PhD, will highlight results from the LENS trial and the efficacy of fenofibrate in the treatment of diabetic retinopathy in a Friday, June 21, symposium.
-
Joint ADA-IPITA symposium will explore current state of beta-cell replacement therapy
A panel of experts will describe recent advances in beta-cell replacement therapy as well as current challenges facing researchers and clinicians. Michiel Nijhoff, MD, MSc, will outline challenges in monitoring and treating transplant recipients for rejection or type 1 diabetes recurrence.
-
Presenter Profile: Omics to Understand Genome-Wide Association Study—What’s the Mechanism?
Nicole Krentz, PhD, previews a presentation at the 84th Scientific Sessions. Attendees in Orlando can watch the session in-person Monday, June 24, at 8:00 a.m. ET, and select recordings will be available on the meeting’s virtual platform after the live presentations.